Allianz Asset Management GmbH - ARRAY BIOPHARMA INC ownership

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$27,469,000
+572.8%
592,903
+254.0%
0.03%
+550.0%
Q1 2019$4,083,000
+68.5%
167,494
-2.1%
0.00%
+33.3%
Q4 2018$2,423,000
-8.8%
171,034
-2.1%
0.00%
+50.0%
Q3 2018$2,656,000
-50.3%
174,725
-45.2%
0.00%
-60.0%
Q2 2018$5,349,000
-9.0%
318,770
-11.5%
0.01%
-16.7%
Q1 2018$5,876,000
+17.7%
360,015
-7.7%
0.01%
+50.0%
Q4 2017$4,992,000
+7.7%
389,985
+3.4%
0.00%0.0%
Q3 2017$4,637,000
+330.5%
377,000
+59.6%
0.00%
+300.0%
Q2 2014$1,077,000
-3.6%
236,277
-0.6%
0.00%0.0%
Q1 2014$1,117,000
-11.6%
237,602
-5.7%
0.00%
-50.0%
Q4 2013$1,263,000
-24.0%
252,031
-5.6%
0.00%0.0%
Q3 2013$1,661,000267,0600.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders